Discussion on critical points for a tailored therapy to cure hepatitis C virus infection

Discussion on critical points for a tailored therapy to cure hepatitis C virus infection

Hepatitis C virus (HCV) infects around 71 million people worldwide and in 2018 it is still a major health problem. Since 2011, anti-HCV therapy with availability of direct-acting antiviral drugs has revolutionized the clinical response and paved the way to eradication strategies. However, despite th...

Full description

Bibliographic Details
Main Authors: Nadia Marascio, Angela Quirino, Giorgio Settimo Barreca, Luisa Galati, Chiara Costa, Vincenzo Pisani, Maria Mazzitelli, Giovanni Matera, Maria Carla Liberto, Alfredo Focà, Carlo Torti
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2019-03-01
Series:Clinical and Molecular Hepatology
Subjects:
Direct-acting antivirals
Resistance-associated substitutions
Genetic variation
Deep sequencing
Online Access:http://e-cmh.org/upload/pdf/cmh-2018-0061.pdf

Similar Items

Similar Items